AH BIO FUND II, L.P. purchased 16.2% of their position (333.33K shares) of SCRIBE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $5.00M — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/29/2026ACC: 0001231919-26-000813
10% Owner
Since Jul 2026
-13.20M
Net shares
Net seller
$5.00M
Total acquired
1
Open market trades
1B · 0S
5
Total transactions
3.08M acquired · 16.28M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+2.05M
Price / share
—
Trade value
—
% of position
New position
7/27/2026
0.00→2.05M
Common Stock
Indirect
Shares
+697.65K
Price / share
—
Trade value
—
% of position
New position
7/27/2026
0.00→697.65K
Common Stock
Indirect
Shares
+333.33K
Price / share
$15.00
Trade value
$5M
% of position
16.2%
7/27/2026
2.05M→2.39M
Total
Net shares
+3.08M
Net value
$5M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/27/2026 | C · Conversion | +2.05M | — | — | New position | 0.00 | 2.05M |
| Common Stock Indirect | 7/27/2026 | C · Conversion | +697.65K | — | — | New position | 0.00 | 697.65K |
| Common Stock Indirect | 7/27/2026 | P · Purchase | +333.33K | $15.00 | $5M | 16.2% | 2.05M | 2.39M |
| Total | +3.08M | $5M | ||||||
Derivative Transactions2
Series A Preferred Stock
Indirect
Converts to
Common Stock
2.05M shares
Shares
−12.15M
Strike price
Held after
0.00
Exercisable
—
7/27/2026
Series B Preferred Stock
Indirect
Converts to
Common Stock
697.65K shares
Shares
−4.13M
Strike price
Held after
0.00
Exercisable
—
7/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock2.05M shares | 7/27/2026 | C · Conversion | −12.15M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock697.65K shares | 7/27/2026 | C · Conversion | −4.13M | — | 0.00 |